Newsletter | October 29, 2026

10.29.26 -- Where Should Medtech Startups Launch First-In-Human Trials?

FEATURED EDITORIAL

Beyond Australia: Why Medtech Startups Are Re-Evaluating FIH Trial Destinations

The advice handed to medtech companies planning a first-in-human (FIH) study has been: go to Australia. That advice is now overdue for a rewrite. Not because Australia stopped working, but because the math changed.

INDUSTRY INSIGHTS

Advancing Biopsy Device Performance Through Precision Overmolding

Early design alignment resolves tolerance stack-ups and maintains sample accuracy. Navigating process validation and automated assembly accelerates commercialization.

Continuous Readiness Is Becoming The New Operating Standard In MedTech

Transitioning from episodic audit preparation to continuous readiness stabilizes submission timelines and aligns compliance dynamically with product development.

What 9 Years Of MDR Experience Is Changing About PMCF Planning

Re-evaluate your compliance roadmap by exploring expert perspectives on navigating regulatory shifts, distinguishing core surveillance obligations, and building a defensible, value-driven clinical data strategy.

Meeting The Demands Of Pulse Power Applications

Pulse power technologies require precise, repeatable energy delivery across various systems driving demand for high-performance capacitors engineered for reliability and control.

Improve Flow Cell Performance While Cutting System Costs

Explore pump and valve strategies that improve flow control in microfluidic sequencing and PCR systems—boosting reliability, reducing reagent waste, and lowering overall instrument costs.

RESOURCES

Pharma+ Tubing Retainers Datasheet

Intuitive Custom Tubing Assembly

Connect With Med Device Online: